Dosing & Uses
AdultPediatric
Exudative Age-Related Macular Degeneration
Pending FDA approval for exudative (neovascular, wet) age-related macular degeneration (AMD)
Safety and efficacy not established
Next:
Pharmacology
Mechanism of Action
Nonimmunoglobulin protein; designed ankyrin repeat protein (DARPin) that targets vascular endothelial growth factor- A (VEGF-A)
VEGF is a key mediator in ocular angiogenesis
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
